Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
Clinical trial NCT01621100 · COMPLETED
Trial details
- NCT number
- NCT01621100
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-09-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.